TXA for GI Bleeds? The HALT-IT Trial

July 15, 2020 00:26:28
TXA for GI Bleeds?  The HALT-IT Trial
Critical Care Perspectives in Emergency Medicine
TXA for GI Bleeds? The HALT-IT Trial
/

Show Notes

The use of tranexamic acid (TXA) has markedly increased since the results of the CRASH-II trial were published.  In addition to its use in trauma, TXA has been evaluated and used in numerous other conditions, including post-partum hemorrhage and epistaxis.  Recently, the HALT-IT Trial was published online in the Lancet, which evaluated the use of TXA in patients with acute gastrointestinal bleeding.  In this podcast we discuss the HALT-IT Trial and its implications for clinical practice. 

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode

April 17, 2019 00:22:01
Episode Cover

Tips for the Renal Transplant Patient

Renal transplants are one of the most common organ transplants worldwide.  Renal transplant patients can quickly succumb to illness and present to the ED or be admitted to the ICU in need of urgent resuscitation.  In this podcast, we discuss critical pearls and pitfalls in managing the renal transplant patient. Download Companion HandoutDownload You can get CME credit for this episode here! Click here for CME Account Creation Instructions ...

Listen

Episode

March 26, 2018 00:31:51
Episode Cover

Managing Acute on Chronic Liver Failure

These are some of the sickest patients you’ll see in the ED and ICU. In this episode, we discuss incredibly useful pearls and pitfalls in the management of acute on chronic liver failure. Download Companion HandoutDownload You can get CME credit for this episode here! ...

Listen

Episode

December 27, 2019 00:23:35
Episode Cover

Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?

Up to one-third of patients with status epilepticus will not respond to benzodiazepines.  Unfortunately, treatment of benzodiazepine-refractory status epilepticus is not well studied.  The longer seizures persist, the worse patients do.  In this podcast, we discuss the results of the recently completed ESETT trial that evaluated three anticonvulsant medications for status epilepticus. Download Companion HandoutDownload You can get CME credit for this episode here!Click here for CME Account Creation Instructions ...

Listen